3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Lymphoid
1
Genitourinary
1
Conditions
Multiple Myeloma
444
Lymphoma
55
Recurrence
44
Neoplasms, Plasma Cell
35
Immunoglobulin Light-chain Amyloidosis
34
Hematologic Neoplasms
34
Smoldering Multiple Myeloma
28
Lymphoma, Non-Hodgkin
26
Leukemia, Myeloid, Acute
22
Leukemia, Lymphocytic, Chronic, B-Cell
21
Neoplasms
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Hodgkin Disease
18
Myelodysplastic Syndromes
17
Monoclonal Gammopathy of Undetermined Significance
13
Leukemia
12
Waldenstrom Macroglobulinemia
11
Lymphoma, Mantle-Cell
11
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
11
Breast Neoplasms
11
Prostatic Neoplasms
10
Lymphoma, Large B-Cell, Diffuse
10
Paraproteinemias
9
Ovarian Neoplasms
9
Amyloidosis
9
Lung Neoplasms
8
Leukemia, Plasma Cell
8
Primary Myelofibrosis
7
Melanoma
7
Lymphoma, Follicular
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vascular Diseases
×
Plasma cell
×
90 days
×
Clear all
NCT07075185
2026-04-24
inMMyCAR
Kelonia Therapeutics, Inc.
Phase 1
Recruiting
70 enrolled